home.aspx
 
EVENTS

Update CME - Internal Medicine & Primary Care
UPDATE CME - INTERNAL MEDICINE & PRIMARY CARE
October 29-01, 2020
Earn 30 CME Credits by attending our Update CME Internal Medicine and Primary Care Conference either in person or via live stream!Expert speakers from The University of Chicago, Johns Hopkins, and University of California, Los Angeles will be presenting on the latest clinical guidelines. We offer in...

Internal Medicine for Primary Care
INTERNAL MEDICINE FOR PRIMARY CARE
October 30-01, 2020
The Internal Medicine for Primary Care conference will cover areas like Internal Medicine for Primary Care Physicians, Issues in Women's Health Cardio, Pulmonary for Primary Care Physicians, Neurology for the Non-Neurologist.

Clear Genetics (YC W17)

SHARESHARESHARE
We are reinventing the way people around the world access genetic expertise. Clear Genetic is developing a medical platform for patients, genetic counselors and physicians. With the burgeoning industry of genetic testing, every patient today needs easy access to genetic experts. We are building an experience that leverages technology and best medical practice to provide vastly improved patient care around genetics.
SHARESHARESHARE

RELATED NEWS


Two injected drugs manufactured by an Indian company with a history of sterility problems are being recalled because of microbial contamination. The drugs were both manufactured by Emcure Pharmaceuticals but are distributed in the U.S. by Heritage Pharmaceuticals.East Brunswick, New Jersey-based Heritage Saturday issued the voluntary recall to the consumer level for sublots of infection fighter amikacin sulfate injection and schizophrenia drug prochlorperazine edisylate after microbial growth wa...

READ MORE

Australian biotech Immutep has begun a clinical trial partnership with Germany’s Merck KGaA and Pfizer to develop a new cancer immunotherapy combination therapy. Sydney-based Immutep will develop its immunotherapy eftilagimod alpha (left) in combination with Merck and Pfizer’s anti PD-L1 antibody avelumab in patients with advanced solid tumors.
A planned clinical evaluation will be an amendment to the existing INSIGHT phase I clinical trial and will evaluate the safety, tolera...


READ MORE

Development of a stem cell therapy for sickle cell disease from Vertex and development partner CRISPR therapeutics can go ahead after the FDA lifted a hold on a review. The companies had applied to begin an early-stage trial of CTX001, a gene therapy derived from a patient’s own stem cells, for beta-thalassemia and sickle cell disease. Although it’s a long way from the market, the drug could be one of the first to use the revolutionary CRISPR/Cas9 gene editing technology to correct a...

READ MORE

Shares in Axovant Sciences Ltd sank almost 50 percent after investors shrank back on new of the failure of lead drug intepirdine in a mid-stage study in patients with a particular kind of dementia. The company said the investigational drug did not meet its primary efficacy endpoints in the Phase IIb HEADWAY and pilot Phase II Gait and Balance studies, which assessed its potential in patients with patients with dementia with Lewy bodies (DLB). In the HEADWAY study, neither 35mg or 70mg dose of in...

READ MORE

Purdue Pharma L.P. and Exicure, Inc. today announced a strategic research collaboration, option and license agreement to discover and develop a treatment for psoriasis, and other diseases amenable to a gene regulation approach utilizing Exicure’s Spherical Nucleic Acid (SNA)™ technology. Purdue Pharma, upon exercise of the options, will obtain full worldwide development and commercial rights to AST-005, and rights to three additional collaboration targets with associated intellectual property....

READ MORE

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it will provide 160,000 drug deactivation pouches to families in Kentucky as well as across the U.S. Midwest and Central Appalachia to encourage the safe and responsible disposal of leftover prescription pain medications....
WWW.MALLINCKRODT.COM
READ MORE

EVENTS

Internal Medicine for Primary Care
INTERNAL MEDICINE FOR PRIMARY CARE
October 30-01, 2020
The Internal Medicine for Primary Care conference will cover areas like Internal Medicine for Primary Care Physicians, Issues in Women's Health Cardio, Pulmonary for Primary Care Physicians, Neurology for the Non-Neurologist.

Update CME - Internal Medicine & Primary Care
UPDATE CME - INTERNAL MEDICINE & PRIMARY CARE
October 29-01, 2020
Earn 30 CME Credits by attending our Update CME Internal Medicine and Primary Care Conference either in person or via live stream!Expert speakers from The University of Chicago, Johns Hopkins, and University of California, Los Angeles will be presenting on the latest clinical guidelines. We offer in...